NHS drug suppliers investigated over prices
Competition watchdog launches investigation after claims prices of 32 drugs rose 1,000% in five years
The competition watchdog has launched an investigation into drug companies accused of charging the NHS excessive prices.
If the companies are found by the the Competition and Markets Authority to have broken the law, they could face fines of up to 10% of their turnover.
No comments:
Post a Comment